Evaluation of a New Silicone Hydrogel Contact Lens
Study Details
Study Description
Brief Summary
The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Air Optix Aqua Ciba Vision daily wear contact lens |
Device: Air Optix Aqua
Air Optix Aqua contact lens worn on a daily wear basis
|
Experimental: Test Lens Investigational silicone hydrogel contact lens |
Device: Test lens
Investigational silicone hydrogel contact lens worn on a daily wear basis
|
Outcome Measures
Primary Outcome Measures
- Visual Acuity [Dispensing & 1-week follow up]
Distance high contrast logMAR lens visual acuity (VA) between the Air Optix Aqua lens and the Test Lens at Dispensing and at 1-Week Follow-up.
Secondary Outcome Measures
- Slit Lamp Findings [1 week]
Measured on a scale of 0-4 where 0=none, 1=trace, 2=mild, 3=moderate, and 4=severe for edema, microcysts, corneal staining, limbal injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization and corneal infiltrates.
- Comfort [1 Weeks]
At 1-Week Follow-up, participants rated lens comfort on a scale of 0 to 100, with 100 being the most favorable score.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
-
Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
Exclusion Criteria:
-
Have worn gas permeable (GP) contact lenses within last 30 days or polymethylmethacrylate (PMMA) lenses within last 3 months.
-
Any systemic disease affecting ocular health.
-
Using any systemic or topical medications that will affect ocular physiology or lens performance.
-
An active ocular disease, any corneal infiltrative response or are using any ocular medications.
-
Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
-
Allergic to any component in the study care products.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Bausch & Lomb, Incorporated | Rochester | New York | United States | 14609 |
Sponsors and Collaborators
- Bausch & Lomb Incorporated
Investigators
- Study Director: Beverly Barna, Bausch & Lomb Incorporated
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 686E
Study Results
Participant Flow
Recruitment Details | This study was a randomized, bilateral, subject-masked, two-week study with a crossover at one week, conducted at three sites in the United States (US). First participant was enrolled on 12/01/2010, last participant exited the study on 12/23/2010. |
---|---|
Pre-assignment Detail | A total of 66 participants (132 eyes) were enrolled in the study. One-half (33) were randomized to receive the investigational RD2117-01 ID4 contact lens first, and the other half (33) was randomized to receive the Air Optix Aqua contact lens first then crossed over after 1 week. All participants completed the study. |
Arm/Group Title | Air Optix Aqua Then Test Lens | Test Lens Then Air Optix Aqua |
---|---|---|
Arm/Group Description | Ciba Vision Air Optix Aqua contact lens. Lenses were worn on a daily wear basis. After one week participants crossed over to the Test lens. All subjects were provided with Bausch + Lomb renu® fresh™ multi-purpose solution and lens cases for daily rinsing, cleaning, disinfecting, and storing their lenses, and Bausch + Lomb Sensitive Eyes® Rewetting Drops for use as needed during the study. | The test lens was an Investigational silicone hydrogel contact lens. Lenses were worn on a daily wear basis. After one week participants crossed over to Ciba Vision Air Optix Aqua contact lens.. All subjects were provided with Bausch + Lomb renu® fresh™ multi-purpose solution and lens cases for daily rinsing, cleaning, disinfecting, and storing their lenses, and Bausch + Lomb Sensitive Eyes® Rewetting Drops for use as needed during the study. |
Period Title: Overall Study | ||
STARTED | 33 | 33 |
COMPLETED | 33 | 33 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Overall Study |
---|---|
Arm/Group Description | One-half of the participants (33) were randomized to receive the investigational RD2117-01 ID4 contact lens, and the other half (33) was randomized to receive the Air Optix Aqua contact lens. Both groups wore the lenses on a daily wear basis. After one week of wearing the first lens type, the subjects returned for an exam and crossed over to the second lens type for one week. |
Overall Participants | 66 |
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
36.2
(9.6)
|
Sex: Female, Male (Count of Participants) | |
Female |
47
71.2%
|
Male |
19
28.8%
|
Region of Enrollment (participants) [Number] | |
United States |
66
100%
|
Outcome Measures
Title | Visual Acuity |
---|---|
Description | Distance high contrast logMAR lens visual acuity (VA) between the Air Optix Aqua lens and the Test Lens at Dispensing and at 1-Week Follow-up. |
Time Frame | Dispensing & 1-week follow up |
Outcome Measure Data
Analysis Population Description |
---|
All Eligible, Dispensed Eyes |
Arm/Group Title | Air Optix Aqua | Test Lens |
---|---|---|
Arm/Group Description | Ciba Vision daily wear contact lens Air Optix Aqua: Air Optix Aqua contact lens worn on a daily wear basis | Investigational silicone hydrogel contact lens Test lens: Investigational silicone hydrogel contact lens worn on a daily wear basis |
Measure Participants | 66 | 66 |
Measure eyes | 132 | 132 |
Dispensing |
-0.083
(0.071)
|
-0.085
(0.071)
|
1-Week Follow-up |
-0.084
(0.077)
|
-0.078
(0.077)
|
Title | Slit Lamp Findings |
---|---|
Description | Measured on a scale of 0-4 where 0=none, 1=trace, 2=mild, 3=moderate, and 4=severe for edema, microcysts, corneal staining, limbal injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization and corneal infiltrates. |
Time Frame | 1 week |
Outcome Measure Data
Analysis Population Description |
---|
All Dispensed Eyes |
Arm/Group Title | Air Optix Aqua | Test Lens |
---|---|---|
Arm/Group Description | Ciba Vision daily wear contact lens Air Optix Aqua: Air Optix Aqua contact lens worn on a daily wear basis | Investigational silicone hydrogel contact lens Test lens: Investigational silicone hydrogel contact lens worn on a daily wear basis |
Measure Participants | 66 | 66 |
Measure eyes | 132 | 132 |
Grade 0 |
46
|
82
|
Grade 1 |
86
|
50
|
Grade 2 |
0
|
0
|
> Grade 2 |
0
|
0
|
Title | Comfort |
---|---|
Description | At 1-Week Follow-up, participants rated lens comfort on a scale of 0 to 100, with 100 being the most favorable score. |
Time Frame | 1 Weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Air Optix Aqua | Test Lens |
---|---|---|
Arm/Group Description | Ciba Vision daily wear contact lens Air Optix Aqua: Air Optix Aqua contact lens worn on a daily wear basis | Investigational silicone hydrogel contact lens Test lens: Investigational silicone hydrogel contact lens worn on a daily wear basis |
Measure Participants | 66 | 66 |
Measure eyes | 132 | 132 |
Least Squares Mean (Standard Deviation) [units on a scale] |
85.5
(19.5)
|
81.8
(19.5)
|
Adverse Events
Time Frame | 1 week | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Air Optix Aqua | Test Lens | ||
Arm/Group Description | Ciba Vision daily wear contact lens Air Optix Aqua: Air Optix Aqua contact lens worn on a daily wear basis | Investigational silicone hydrogel contact lens Test lens: Investigational silicone hydrogel contact lens worn on a daily wear basis | ||
All Cause Mortality |
||||
Air Optix Aqua | Test Lens | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
Air Optix Aqua | Test Lens | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/66 (0%) | 0/66 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Air Optix Aqua | Test Lens | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/66 (0%) | 0/66 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
Results Point of Contact
Name/Title | Dr. Robert Steffen |
---|---|
Organization | Bausch & Lomb |
Phone | 585 338 6399 |
robert.steffen@bausch.com |
- 686E